Indwelling Catheters Market
Indwelling Catheters Market Report By Product (2-way, 3-way, 4-way), By Material (Latex, Silicone), By Coating Type (Hydrogel, Silver Alloy, Silicone-elastomer), By Application (Short-term, Long-term), By End User (Hospitals, Long-term Care Facilities) - Regional Forecast, 2021-2031
Indwelling Catheters Market Outlook
The sales of indwelling catheters will exceed US$ 1 Bn by the end of 2021. Demand for best-in-class patient care is surging at an exponential pace, compelling healthcare providers to seek out latest technologies.
In addition, demand from regions like North America and Europe is positively influencing the sales of indwelling catheters. This is further reiterated by the growth forecasts for the indwelling catheters market, which, according to Fact.MR, is likely to reach nearly US$ 2 Bn by registering a CAGR of 7% in the sales indicator period 2021-2031.
|Market Size Value in 2021||US$ 1 Bn|
|Project Market Forecast Value in 2031||US$ 2 Bn|
|Global Growth Rate (2021-2031)||7.2% CAGR|
|Market Share of North America||45%|
Demand Analysis of Indwelling Catheters from 2016 to 2020 Vs Market Projections for 2021 to 2031
Historical analysis of the market concludes that indwelling catheters demand experienced positive acceleration, with an estimated value CAGR worth 5%. Sales of indwelling catheters have largely surged on the back of increased incidences of urinary tract surgeries.
During the COVID-19 pandemic, sales experienced a major uptick, as prominent med-tech companies introduced therapeutic devices to minimize human-to-human contact during critical surgical procedures. This device, which recently received approval from the Therapeutic Goods Administration, is designed to prevent bacterial and viral colonization and biofilm on indwelling urinary catheters, increasing antibiotic efficacy.
Manufacturers of indwelling catheters are focusing on the durability of catheters. In addition, increasing geriatric population around the world along with growing urinary problems is propelling the demand for indwelling catheters. Thus, in the forecast period, the sales of indwelling catheters exceeded US$ 2 Bn by registering a CAGR of 7% through 2021-2031.
Interested to Procure The Data
Increasing Cases of Urinary Incontinence Surging Demand for Indwelling Catheters?
Rising demand for bridging the knowledge gap between evidence and practice is pushing healthcare professionals to educate themselves about advanced healthcare practices, so as to offer improved medical outcomes, especially to patients with bladder issues.
Besides surging prevalence of urinary incontinence, increasing number of surgeries conducted worldwide, rising incidence of kidney stones, urethra blockage, and benign prostatic hyperplasia (BPH), among others has made indwelling catheters imperative for certain treatment measures, which bodes well for the expansion of the global indwelling catheters market size over the coming years.
According to data published by the National Center for Biotechnology Information (NCBI), the incidence of BPH in men above 50 years of age varies from 20% to 62%, especially in countries such as the U.S., Ghana, and Japan. Thanks to recent advancements in indwelling catheters, such patients can now experience greater convenience and comfort, which is one of the chief factors driving the indwelling catheters market.
On the downside though, chances of complications such as tissue damage and catheter-associated urinary tract infections (CAUTIs) can make these healthcare products undesirable by patients and their caretakers. Various companies operating within the indwelling catheters market, therefore, are taking steps and investing in campaigns to spread awareness about various catheter selection parameters to avoid the risk of complications in patients.
Are Prostate Gland Treatments Fuelling Demand for Indwelling Catheters?
Urinary catheters are frequently used in prostate gland medical procedures, especially for patients experiencing BPH. In one of its studies, the American Academy of Family Physicians (AAFP) found that, nearly 250,000 surgeries are conducted in the U.S. for BPH treatment, with nearly 2 million office visits.
The condition might as well emerge by virtue of damage or injury to the urethra, bladder, or penis, and is often associated with pregnancy in women. Use of urinary catheters in prostate gland surgery also is pretty common. Considering the surging demand witnessed in the market, some of the leading players in the indwelling catheters market are focusing on the development of technologically-advanced products to curb the incidence of urinary tract infections (UTIs), while allowing urologists to offer improved patient care.
This has led to the launch of intermittent urinary catheters, produced using hydrophilic technology, which helps in enhancing their antibacterial properties. Some producers are even experimenting with diverse kinds of coatings to meet the needs of physicians. Spurred by these factors, the indwelling catheters market will surge positively over the coming years.
An Adaptive Approach to Modern-day Research Needs
Bladder Problems Propelling Demand for Indwelling Catheters in North America?
According to the American Academy of Family Physicians (AAFP), over 250,000 surgeries for Benign Prostatic Hyperplasia (BPH) are conducted every year in the U.S., which accounts for nearly 2 million office visits. This, in turn, is likely to boost sales of indwelling catheters in North America.
Studies suggest that, bladder problems are alarmingly high among patients in the U.S. It has also been found that, community caseloads are swelling at an unprecedented pace. This has, in turn, fuelled demand for indwelling catheters in hospital settings.
Thus, according to Fact.MR, North America will account nearly 45% of market share throughout the assessment period. Increasing number of urological surgeries conducted in the U.S. has been fuelling demand for indwelling catheters in the region.
Healthcare Sector Attracting Demand for Indwelling Catheters in Europe?
The indwelling catheters market in Europe is expected to expand at an impressive pace. Presence of several leading companies will aid this expansion, which also is expected to be backed by the region’s sophisticated healthcare infrastructure.
In addition, countries like France and Sweden provide the best treatment for urinary infections and problems. Furthermore, rising inclination towards taking treatment from these countries has favoured the sales of indwelling catheters. Thus, Europe is expected to possess 35% market share for indwelling catheters in the assessment period.
Increasing Geriatric Population Upscale Use of Indwelling Catheters in Asia?
Countries such as China and India have observed an increase in the geriatric population. This, in turn, has diagnosed people with urinary problems. Moreover, funding from the government for indwelling catheters is positively influencing the sales of the same.
In addition, growing concern towards health along with technological advancements in the healthcare sector is boosting the sales of indwelling catheters. Thus, Asia is expected to register nearly 25% of market share for indwelling catheters in the sales indicator period.
Cost-efficiency Boosting Demand for 2-Way Catheters?
In terms of product, demand witnessed in the two-way segment is comparatively higher than the rest. The segment will continue exhibiting robust growth on account of their cost-efficiency in comparison to other products available in the market. Thus, they are expected to hold nearly 50% market share throughout the forecast period.
Over the coming years, demand for three-way indwelling catheters is forecast to showcase an impressive surge as well, due to their features such as bladder irrigation during surgeries or after, and an extra lumen for medicine installation. Sales of 3-way indwelling catheters will likely register a growth rate worth 6% until 2031.
High Flexibility Upticking Latex Indwelling Catheters Popularity?
Latex and silicone are preferred choices of materials for manufacturing indwelling catheters. Studies suggest that latex indwelling catheters are flexible in nature and come at a lower cost. They are therefore preferred for short-term catheterization.
Furthermore, latex indwelling catheters are extremely soft, enhancing comfort levels of patients, and are coated with a protective layer. According to Fact.MR, latex based indwelling catheters are expected to possess around 40% market share throughout the assessment period.
Why is there Increasing Preference for Hydrogel Indwelling Catheters?
By coating type, the hydrogel indwelling catheters emerged dominant in 2019, and is expected to remain highly popular through the course of the forecast period.
Hydrogel-coated latex catheters are considered more durable than their silicone counterparts. The former prevents bacterial adherence of any sort, and also helps in reducing mucosal friction. Thus, hydrogel coating is expected to accumulate more than 45% market hare for indwelling catheters in the forecast period.
How are ICUs Demanding Propelling the Need of Short-Term Indwelling Catheters?
On the basis of application, the indwelling catheters market can be bifurcated into long-term and short-term usage. Of these, the short-term usage segment is forecast to exhibit a higher rate of growth over the coming years. These catheters are often used for critically-injured patients and those admitted in ICUs.
Therefore, surging number of hospital admissions is expected to augur well for this segment in the global indwelling catheters market. Thus, according to Fact.MR, short-term usage segment is expected to possess nearly 50% market share for indwelling catheters.
Hospitals to Remain Primary Indwelling Catheters End Users?
Hospitals and long-term care facilities are the chief end users of indwelling catheters. Of these, hospitals account for a visibly large share in the indwelling catheters market. The segment is also expected to remain dominant through the course of the forecast period.
In a recently published study, the Journal of Family Medicine and Primary Care stated that, at any time, around 15% to 20% of hospitalized patients in the U.S. use indwelling catheters. This is indicative of the surging demand for the segment, which is expected to continue even over the coming period of time. Thus, hospitals are expected to hold around 45% of market share for indwelling catheters.
Avail customized purchase options for your needs
The global market for indwelling catheters is fragmented in nature, and is characterized by the presence of several companies. Leading companies are engaged in research initiatives to offer innovations. This will help the growth of the global indwelling catheters market over the coming years.
- In June 2018, Teleflex Inc. reprocessed over 200,000 ClosureFast® Catheters, along with its partner, Northeast Scientific Inc. The ClosureFast® Catheter is one of the most widely used devices across the U.S for performing endovenous treatment of venous reflux disease
- In October 2021, Becton Dickinson & Company received 510(k) clearance from US Food and Drug Administration for the Rotarex Atherectomy System. This system can treat peripheral arteries fitted with stents, stent grafts and native or artificial bypasses.
- In March 2017, Cardinal Health announced two strategic agreements which would enable its Cordis cardiovascular equipment portfolio across China. These agreements added new percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, given that over 500,000 percutaneous coronary intervention surgeries are performed across China annually
|Historical Data Available for||2016-2020|
|Market Analysis||US$ Mn for Value & ‘000 Units for Volume|
|Key Regions Covered||
|Key Countries Covered||
|Key Segments Covered||
|Key Companies Profiled||
|Pricing||Available upon Request|
Key Segments Covered
- 2-way Indwelling Catheters
- 3-way Indwelling Catheters
- 4-way Indwelling Catheters
- Latex Indwelling Catheters
- Silicone Indwelling Catheters
- Hydrogel Coating Indwelling Catheters
- Silver Alloy Coating Indwelling Catheters
- Silicone-elastomer Indwelling Catheters
- Other Coating Type Indwelling Catheters
- Indwelling Catheters for Short-term Usage
- Post-surgical Care
- Critical Care
- Indwelling Catheters for Long-term Usage
- Urinary Incontinence
- Benign Prostate Hyperplasia
- Indwelling Catheters for Short-term Usage
- Indwelling Catheters for Hospitals
- Indwelling Catheters for Long-term Care Facilities
- Indwelling Catheters for Other End Users
- FAQs -
As of 2021, the market for indwelling catheters is anticipated to reach nearly US$ 1 Bn
The indwelling catheters industry is expected to surpass a CAGR of 7.2% from 2021-2031.
The indwelling catheters market is expected to reach nearly US$ 2 Bn by 2031
Increase in urinary ailments, developments in catheters and investments from governments in healthcare are the key trends driving indwelling catheters sales.
Teleflex Incorporated, Cardinal Health, Inc., Becton, Dickinson & Company, Amsino International, Inc., Medline Industries, Inc., Cook Medical LLC, Coloplast Corp., B. Braun Melsungen AG, SunMed LLC, Bactiguard, and Poiesis Medical LLC are prominent
2-way catheters are expected to hold nearly 50% market share for indwelling catheters.
The indwelling catheters industry is expected to possess nearly 45% market share throughout North America.
The indwelling catheters industry is expected to possess nearly 35% market share throughout Europe
As per Fact.MR, Asia is anticipated to capture 1/4th of global demand for indwelling catheters